Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:45 PM
Ignite Modification Date:
2025-12-24 @ 2:45 PM
NCT ID:
NCT02861859
Eligibility Criteria:
Inclusion Criteria:
* Newly diagnosed invasive breast cancer (stage I-III) scheduled to receive neo/adjuvant anthracycline/cyclophosphamide or platinum-based chemotherapy
* ≥18 years
* Able to provide consent and complete all study-related diaries and questionnaires.
Exclusion Criteria:
* Received previous chemotherapy
* Symptoms of nausea or vomiting at baseline
* On chronic antiemetic therapy (e.g. metoclopramide); on daily long term oral steroids prior to chemotherapy
* Allergic or having a medical condition that makes the administration of olanzapine, aprepitant, 5-HT3 antagonists or dexamethasone contraindicated
* Uncontrolled diabetes
* Known/documented medical/psychiatric illness that would interfere with patients' ability to complete the diary and study-related questionnaires.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02861859
Study Brief:
Protocol Section:
NCT02861859